Medmix Ltd
SIX:MEDX
Net Margin
Medmix Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CH |
|
Medmix Ltd
SIX:MEDX
|
379.8m CHF |
-2%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
216.1B USD |
32%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
165B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
134.9B USD |
11%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
131.5B USD |
13%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
106.9B USD |
13%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59.5B USD |
8%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
48.4B EUR |
9%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
40.6B USD |
77%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
256.5B CNY |
33%
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
31.4B USD |
25%
|
Medmix Ltd
Glance View
medmix AG designs, develops and produces delivery devices for the mixing, application and injection of liquids for the healthcare, consumer and industrial end-markets. The company is headquartered in Zug, Zug and currently employs 2,101 full-time employees. The firm operates in business areas such as: the dental segment, which provides MIXPAC and transcodent - system solutions that are used to dose, mix and apply various types of dental materials; drug delivery- solutions for the dosage and application of drugs; a surgical segment which provides devices for bone regeneration and tissue healing; an industry segment that specializes in the mixing and dosing of sealants and adhesives through IXPAC , COX and MK; and a beauty segment in which it produces cosmetic applicators through the GEKA brand.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Medmix Ltd's most recent financial statements, the company has Net Margin of -1.5%.
You don't have any saved screeners yet